In our case, the therapeutic targeting of ALB in NSCs may be the key to mitigating intracranial hypertension in astronauts, and radiation deserves deeper investigation as a subject with the aim of producing combinatorial therapies for the successful future of space exploration. The gene discussed is ALB; the disease is intracranial hypertension.